 |
Deferasirox |
|---|---|
| Trade Name | Exjade; Jadenu Sprinkles |
| Orphan Indication | Chronic iron overload in patients with transfusion-dependent anemias |
| USA Market Approval | USA |
| USA Designation Date | 2002-11-21 00:00:00 |
| Sponsor | Novartis Pharmaceuticals Corp.;One Health Plaza;East Hanover, New Hampshire, 07936 |
